Positron emission tomography (PET) is a non-invasive imaging technology that can reveal
molecular alterations in the brains of Alzheimer's disease (AD) patients with high sensitivity …

Chronic innate immune activation is a key hallmark of many neurological diseases and is
known to result in the upregulation of GPR84 in myeloid cells (macrophages, microglia, and …

Azines are an important class of compounds that display solvent-dependent fluorescence
emission depending upon the substituents in the aromatic scaffolds. They are affordable …

Translational Science, we attempted to capture some of the advances in the field of
radiolabeled pharmaceuticals for imaging and therapy. Positron emission tomography (PET) …

The broader utilization of 64Cu positron emission tomography (PET) imaging agents has
been hindered by the unproductive demetalation induced by bioreductants. To advance the …

Positron emission tomography (PET) imaging of amyloid-β (Aβ) has emerged as a crucial
strategy for early diagnosis and monitoring of therapeutic advancements targeting Aβ. In our …

Nuclear imaging of aggregated α-synuclein pathology is an urgent clinical need for
Parkinson's disease, yet promising tracers for brain α-synuclein aggregates are still rare. In …

Alzheimer's disease (AD) is a chronic and progressive neurodegenerative disorder with long
preclinical and prodromal phases in older people. Molecular imaging is a promising …